Literature DB >> 11249328

A decade review: methods to improve adherence to the treatment regimen among hemodialysis patients.

L Morgan1.   

Abstract

Hemodialysis patients are asked to adhere to a very difficult treatment regimen consisting of fluid and diet restrictions, many daily medications, and, usually, 3- or 4-hour hemodialysis sessions three times each week. Many hemodialysis patients fail to adhere to their prescribed treatment. Although this regimen is difficult, it is necessary for patients to adhere to the prescribed regimen for optimal health and well-being. It is important for nephrology nurses to know what interventions help patients overcome the barriers that keep them from adhering to the prescribed treatment. The purpose of this paper is to review the literature to examine the research that has been published on methods to improve adherence to the treatment regimen among hemodialysis patients. Behavioral approaches, education, and primary nursing are interventions that have been researched. More research has been reported on the demographics of noncompliant hemodialysis patients than on effective methods that help patients improve adherence to the treatment regimen. Demographic characteristics do not consistently predict compliance for individual patients. Each patient is unique. Research supports the idea that the nephrology nurse should spend time with the patient on a regular basis in order to understand the factors that hinder the individual patient from adhering to the treatment regimen. The nurse who knows the patient well is empowered to develop individualized interventions aimed at reducing barriers that interfere with the patient's ability to adhere the prescribed treatment regimen.

Entities:  

Mesh:

Year:  2000        PMID: 11249328

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


  8 in total

1.  The End-Stage Renal Disease Adherence Questionnaire (ESRD-AQ): testing the psychometric properties in patients receiving in-center hemodialysis.

Authors:  Youngmee Kim; Lorraine S Evangelista; Linda R Phillips; Carol Pavlish; Joel D Kopple
Journal:  Nephrol Nurs J       Date:  2010 Jul-Aug       Impact factor: 0.959

2.  Follow-Up Study on the Effect of Cognitive Behaviour Therapy on Haemodialysis Adherence: A randomised controlled trial.

Authors:  Blessy P Valsaraj; Shripathy M Bhat; Ravindra Prabhu; Asha Kamath
Journal:  Sultan Qaboos Univ Med J       Date:  2021-03-15

3.  Development and cultural adaptation of the Spanish version of the End Stage Renal Disease Adherence Questionnaire (SESRD-AQ).

Authors:  Youngmee Kim; Lorraine S Evangelista
Journal:  Nephrol Nurs J       Date:  2013 Nov-Dec       Impact factor: 0.959

4.  Factors Associated with Hemodialysis Machine Dependency.

Authors:  Maria Polikandrioti; Ioannis Koutelekos; Georgia Gerogianni; Spyridoula Stefanidou; Vasilis Kyriakopoulos; Eirini Floraki; Fotoula Babatsikou
Journal:  Med Arch       Date:  2017-04

5.  Nonadherence in Hemodialysis Patients and Related Factors: A Multicenter Study.

Authors:  Nurten Ozen; Fatma Ilknur Cinar; Dilek Askin; Dilek Mut; Turker Turker
Journal:  J Nurs Res       Date:  2019-08       Impact factor: 1.682

Review 6.  A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.

Authors:  Christina Karamanidou; Jane Clatworthy; John Weinman; Rob Horne
Journal:  BMC Nephrol       Date:  2008-01-31       Impact factor: 2.388

Review 7.  Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review.

Authors:  Saurav Ghimire; Ronald L Castelino; Nicole M Lioufas; Gregory M Peterson; Syed Tabish R Zaidi
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

8.  Hemodialysis Patients' Information and Associated Characteristics.

Authors:  Maria Polikandrioti; Ioannis Koutelekos; George Vasilopoulos; Fotoula Babatsikou; Georgia Gerogianni; Sofia Zyga; George Panoutsopoulos
Journal:  Mater Sociomed       Date:  2017-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.